. In this article we describe the use of fibrin sealant for nerve coaptation without sutures in masseter-to-facial nerve transfer; and the results obtained utilizing this technique in a series of eleven patients.
METHODS:
A retrospective review of the medical records of eleven patients with facial paralysis grades V-VI, who underwent masseter-to-facial nerve transfer for facial reanimation utilizing a fibrin sealant, without utilizing sutures for coaptation, was performed.
RESULTS:
The follow up period ranged from 10 to 52 months. All patients recovered oral competence, eye closure, facial tone and a smile grade of 4,45 +/-0,52 according to Terzis aesthetic and functional evaluation scale. Muscle contraction started 3-9 months postoperatively (average 4,7 +/-2,3).
CONCLUSION:
The use of fibrin glue without sutures for coaptation in masseter-to-facial nerve transfer, simplifies the procedure and shortens surgical timing, not requiring the material logistics of a microsurgical team, with similar results than coaptation performed with sutures. The masseter-to-facial nerve transfer is an effective technique for facial reanimation in short-term complete paralysis and mid-term partial paralysis. Many transgender men seek surgical interventions to create male genitalia. Such procedures are often referred to as "bottom surgery". Phalloplasty and metoidioplasty are the most common procedures. Phalloplasty involves the surgical creation of a penis from a local or free-flap while metoidioplasty makes uses the body of the hormonallyenlarged clitoris as the penile shaft.
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Currently, there is no standardized tool to assess individual goals and expectations for bottom surgery. In this study, our group has designed and administered a questionnaire to determine the preoperative priorities of transgender men seeking phalloplasty and metoidioplasty.
METHODS:
A literature review was conducted in order to identify areas of importance to patients seeking phalloplasty and metoidioplasty. Primary areas of relevance were found to be size, sensation, interest in penetrative sex, ability to urinate standing up, types of sensation, and maintenance of orgasmic function. This information was used to construct an assessment of genital surgery priorities for transmasculine patients. Most questions were structured as five item Likert scales with values ranging from very unimportant to very important. The assessment was then administered to the first eight patients seeking phalloplasty or metoidioplasty at our center.
EXPERIENCE:
Use of the formal assessment increased the information available to the surgical team. Regular multidisciplinary team meetings about patients showed that patients regularly disclosed priorities on the formal assessment that they did not bring up during the clinical exam. The team also found that the assessment tool encouraged additional questions from patients about sexual concerns that did not spontaneously arise elsewhere in the discussion.
RESULTS:
Eight consecutive patients were administered the survey, with a 100 percent response rate. The mean age of patients was 26 years (SD=4.5). All patients (n=8) reported full comprehension of the questions, and both patients who were uncertain of which procedure they wanted stated that it helped clarify their goals and allowed them to choose the most appropriate surgical procedure.
Patients reported a variety of goals for genital surgery. All patients (n=8) rated being able to stand to urinate as "very important". Three patients stated that being able to penetrate a sexual partner was "very important", with the rest of the answers ranging from "unimportant" to "neutral". There was no consensus on the importance of length or girth of the desired phallus. Three patients rated erotic sensation, and three patients tactile sensation, as "very important." All patients stated that they had been able to climax through clitoral stimulation, information that will allow for contextualizing sexual function after surgery.
CONCLUSIONS:
Using a standardized measure improves both patient and clinician understanding of patient priorities around genital surgery. Our findings demonstrate the diversity of patient priorities and consequently emphasize the importance of assessing individual goals in the preoperative period. Of note, our data suggest that transgender men, as a group, value the ability to stand to urinate more highly than they do sexual function. We hope to further assess the range of patient goals for surgery and also prospectively assess how orgasmic function is affected by genital surgery procedures.
INTRODUCTION AND PURPOSE:
Absorptive devices are often used to treat facial bone fractures in Japan. Few reports have investigated whether the plate used was absorbed. 1 We used the OSTEOTRANS MX ® (Takiron Co., Ltd.) in 13 patients with facial bone fractures. In patients in whom the OSTEOTRANS MX ® has been used, it takes 5-6 years until absorption is complete, and then, the device is no longer visible on computed tomography (CT) scans; however, some patients had the device removed due to infection. 2 We describe the decomposition behavior of the extracted plate and screw from patients in whom removal was necessary.
METHODS:
Between August 2008 and June 2014, the OSTEOTRANS MX ® was used in 78 patients with facial bone fracture or posterior malignant tumor reconstruction. Among them, 13 patients (16.7%) required plate removal due to complications from postoperative plate infection. Image observation with a scanning electron microscope (SEM) and elemental analysis by energy dispersive X-ray spectrometry (EDX) were performed. The viscosity average molecular weight and crystallinity were retrospectively measured by an automatic viscometer and differential scanning calorimetry (DSC), respectively.
RESULTS:
Age at surgery ranged from 14 to 80 years (average, 52 ± 20.1 years); there were 8 men and 5 women. The OSTEOTRANS MX ® was removed at the shortest duration, 1 month postoperatively, and at the longest duration, 4 years 6 months after the first operation (average, 16 ± 16.1 months). We did not observe a patient in whom the device was completely absorbed or replaced with the bone, or its shape disappeared. The molecular weight of poly l-lactide (PLLA) decreased with time. The unsintered hydroxyapatite (u-HA) was released from the plate, which created a pore, and the decomposition generally progressed smoothly based on the measurement of crystallinity by DSC.
